Does TUCATINIB Cause Neoplasm malignant? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Neoplasm malignant have been filed in association with TUCATINIB (TUKYSA). This represents 0.3% of all adverse event reports for TUCATINIB.
15
Reports of Neoplasm malignant with TUCATINIB
0.3%
of all TUCATINIB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Neoplasm malignant From TUCATINIB?
Of the 15 reports, 2 (13.3%) resulted in death, 7 (46.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Palmar-plantar erythrodysaesthesia syndrome (355)
Product dose omission issue (332)
Asthenia (322)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TUCATINIB Alternatives Have Lower Neoplasm malignant Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI